Lumara

[Anonymous]

What is with this new name? This is the best name we could come up with? Just drop the price of Makena and problem solved.

 

[Anonymous]

The name change is really working. My doctors are prescribing so much more than they were before. Brilliant idea.

 

[Anonymous]

You can put lipstick on a pig, but it’s still a pig. Until GD and the rest of his teet suckers are gone its all the same. sorry folks nothing her to see.

Insider

 

[Anonymous]

So you are saying this company is a pig?

 

[Anonymous]

So you are saying this company is a pig?

Yep and until upper management is gone it still smells like one too!!

 

[Anonymous]

Start with CD in HR what a joke

 

[Anonymous]

Investors are getting a little worried

Insider

 

[Anonymous]

Investors are getting a little worried

Insider

Ok thanks so much Mr. Insider. The only thing the investors are worried about is the multiple they want to get when they sell the company. Insider go back under your rock now.

 

[Anonymous]

That is in the works.

Insider

 

[Anonymous]

Ok insider-if sale is in the works, when? Will stock/share be sold or entire company? Give some details so us little people can prepare! No cryptic half messages got it? By the way, if you know so much, why are Alere reps being hired?

 

[Anonymous]

So you are saying this company is a pig?

oink, oink, oink

 

[Anonymous]

Insiders wouldn't be talking.
Look who owns company: Private Equity with little healthcare experience, let alone Pharma.
If sales can get ginned up to $150-$175 million, look for either IPO or flip to someone like Teva.
Adding any developmental stage products unlikely, despite much tire kicking.
Board will only allow product additions generating $$ with clear way to add to profits.

Hey haters: Revenue is up. Payers are listening. The new greg knows what he's doing, and is adding some talent to the thin roster. Good things will happen for investors, for sure. And for execs. Employees? Well, not so much.

 

[Anonymous]

Insiders wouldn't be talking.
Look who owns company: Private Equity with little healthcare experience, let alone Pharma.
If sales can get ginned up to $150-$175 million, look for either IPO or flip to someone like Teva.
Adding any developmental stage products unlikely, despite much tire kicking.
Board will only allow product additions generating $$ with clear way to add to profits.

Hey haters: Revenue is up. Payers are listening. The new greg knows what he's doing, and is adding some talent to the thin roster. Good things will happen for investors, for sure. And for execs. Employees? Well, not so much.

Who cares anymore. It's over and has been for good while. Wake us up with we are finally sold.

 

[Anonymous]

I guess pre born babies aren't a real concern for you.
Good luck creep. Greg will be along to fire you soon.

 

[Anonymous]

no one cares and this place is already dead.

 

[Anonymous]

This place will be sold by the end of the year.

 

[Anonymous]

The goofy management couldn't even get the name change right. Lumara is too close to Luminal, and has the potential for screw-ups and possible resultant litigation (Remember that the drug is used on pregnant women, a class of patients that won't take kindly to screw-ups that could have been avoided by selecting a drug product name that was unique and different from any other drug product)

And you guys say that we have a "new" Greg, and additional seasoned executives? Yet, they make a product name change that was not too smart (Makena to Lumara).... any seasoned marketing/sales or pharma executive would have considered prescribing mix-ups caused by similar name products.

 

[Anonymous]

That's the company's and not the product name.

 

[Anonymous]

The goofy management couldn't even get the name change right. Lumara is too close to Luminal, and has the potential for screw-ups and possible resultant litigation (Remember that the drug is used on pregnant women, a class of patients that won't take kindly to screw-ups that could have been avoided by selecting a drug product name that was unique and different from any other drug product)

And you guys say that we have a "new" Greg, and additional seasoned executives? Yet, they make a product name change that was not too smart (Makena to Lumara).... any seasoned marketing/sales or pharma executive would have considered prescribing mix-ups caused by similar name products.

Uh, you don't even know what you are talking about. There were no product name changes. Have a clue before posting idiot.

 

[Anonymous]

Does anyone really know what's going on here? I doubt it!